Consequently, subgroup differences and nominally significant findings for secondary angiographic endpoints should be regarded as exploratory, particularly given the multiplicity of comparisons.
← all excerpts
Impact of prior intravenous thrombolysis on first-line thrombectomy strategy. A secondary analysis of the VECTOR trial.
1
—
—